BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Worth AA, Shoop R, Tye K, Feetham CH, D'Agostino G, Dodd GT, Reimann F, Gribble FM, Beebe EC, Dunbar JD, Alexander-Chacko JT, Sindelar DK, Coskun T, Emmerson PJ, Luckman SM. The cytokine GDF15 signals through a population of brainstem cholecystokinin neurons to mediate anorectic signalling. Elife 2020;9:e55164. [PMID: 32723474 DOI: 10.7554/eLife.55164] [Cited by in Crossref: 10] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Igual Gil C, Coull BM, Jonas W, Lippert RN, Klaus S, Ost M. Mitochondrial stress-induced GFRAL signaling controls diurnal food intake and anxiety-like behavior. Life Sci Alliance 2022;5:e202201495. [DOI: 10.26508/lsa.202201495] [Reference Citation Analysis]
2 Senesi P, Ferrulli A, Luzi L, Terruzzi I. Chrono-communication and cardiometabolic health: The intrinsic relationship and therapeutic nutritional promises. Front Endocrinol 2022;13:975509. [DOI: 10.3389/fendo.2022.975509] [Reference Citation Analysis]
3 Klein AB, Nicolaisen TS, Johann K, Fritzen AM, Mathiesen CV, Gil C, Pilmark NS, Karstoft K, Blond MB, Quist JS, Seeley RJ, Færch K, Lund J, Kleinert M, Clemmensen C. The GDF15-GFRAL pathway is dispensable for the effects of metformin on energy balance. Cell Rep 2022;40:111258. [PMID: 36001956 DOI: 10.1016/j.celrep.2022.111258] [Reference Citation Analysis]
4 Cheng W, Gordian D, Ludwig MQ, Pers TH, Seeley RJ, Myers MG Jr. Hindbrain circuits in the control of eating behaviour and energy balance. Nat Metab 2022;4:826-35. [PMID: 35879458 DOI: 10.1038/s42255-022-00606-9] [Reference Citation Analysis]
5 Pan W, Godoy RS, Cook DP, Scott AL, Nurse CA, Jonz MG. Single-cell transcriptomic analysis of neuroepithelial cells and other cell types of the gills of zebrafish (Danio rerio) exposed to hypoxia. Sci Rep 2022;12:10144. [PMID: 35710785 DOI: 10.1038/s41598-022-13693-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Valenzuela-Vallejo L, Chrysafi P, Bello-Ramos J, Bsata S, Mantzoros CS. Circulating total and intact GDF-15 levels are not altered in response to weight loss induced by liraglutide or lorcaserin treatment in humans with obesity. Metabolism 2022;133:155237. [PMID: 35700837 DOI: 10.1016/j.metabol.2022.155237] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ghidewon M, Wald HS, McKnight AD, De Jonghe BC, Breen DM, Alhadeff AL, Borner T, Grill HJ. Growth differentiation factor 15 (GDF15) and semaglutide inhibit food intake and body weight through largely distinct, additive mechanisms. Diabetes Obes Metab 2022;24:1010-20. [PMID: 35129264 DOI: 10.1111/dom.14663] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Dai Y, Chen S, Li Y, Zhang G, Bi P, Nie K. Liujunzi Decoction ameliorated cisplatin-induced anorexia by inhibiting the JAK-STAT signaling pathway and coordinating anorexigenic and orexigenic neuropeptides in rats. J Ethnopharmacol 2022;285:114840. [PMID: 34800646 DOI: 10.1016/j.jep.2021.114840] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Conte M, Giuliani C, Chiariello A, Iannuzzi V, Franceschi C, Salvioli S. GDF15, an emerging key player in human aging. Ageing Res Rev 2022;75:101569. [PMID: 35051643 DOI: 10.1016/j.arr.2022.101569] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
10 Chow CFW, Guo X, Asthana P, Zhang S, Wong SKK, Fallah S, Che S, Gurung S, Wang Z, Lee KB, Ge X, Yuan S, Xu H, Ip JPK, Jiang Z, Zhai L, Wu J, Zhang Y, Mahato AK, Saarma M, Lin CY, Kwan HY, Huang T, Lyu A, Zhou Z, Bian ZX, Wong HLX. Body weight regulation via MT1-MMP-mediated cleavage of GFRAL. Nat Metab 2022. [PMID: 35177851 DOI: 10.1038/s42255-022-00529-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
11 Klein AB, Kleinert M, Richter EA, Clemmensen C. GDF15 in Appetite and Exercise: Essential Player or Coincidental Bystander? Endocrinology 2022;163:bqab242. [PMID: 34849709 DOI: 10.1210/endocr/bqab242] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Tu L, Liu JYH, Lu Z, Cui D, Ngan MP, Du P, Rudd JA. Insights Into Acute and Delayed Cisplatin-Induced Emesis From a Microelectrode Array, Radiotelemetry and Whole-Body Plethysmography Study of Suncus murinus (House Musk Shrew). Front Pharmacol 2021;12:746053. [PMID: 34925008 DOI: 10.3389/fphar.2021.746053] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Reiner BC, Crist RC, Borner T, Doyle RP, Hayes MR, De Jonghe BC. Single nuclei RNA sequencing of the rat AP and NTS following GDF15 treatment. Mol Metab 2021;:101422. [PMID: 34942400 DOI: 10.1016/j.molmet.2021.101422] [Reference Citation Analysis]
14 Johann K, Kleinert M, Klaus S. The Role of GDF15 as a Myomitokine. Cells 2021;10:2990. [PMID: 34831213 DOI: 10.3390/cells10112990] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
15 Wang D, Day EA, Townsend LK, Djordjevic D, Jørgensen SB, Steinberg GR. GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease. Nat Rev Endocrinol 2021. [PMID: 34381196 DOI: 10.1038/s41574-021-00529-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 33.0] [Reference Citation Analysis]
16 Sabatini PV, Frikke-Schmidt H, Arthurs J, Gordian D, Patel A, Rupp AC, Adams JM, Wang J, Beck Jørgensen S, Olson DP, Palmiter RD, Myers MG Jr, Seeley RJ. GFRAL-expressing neurons suppress food intake via aversive pathways. Proc Natl Acad Sci U S A 2021;118:e2021357118. [PMID: 33593916 DOI: 10.1073/pnas.2021357118] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
17 Cimino I, Kim H, Tung YCL, Pedersen K, Rimmington D, Tadross JA, Kohnke SN, Neves-Costa A, Barros A, Joaquim S, Bennett D, Melvin A, Lockhart SM, Rostron AJ, Scott J, Liu H, Burling K, Barker P, Clatworthy MR, Lee EC, Simpson AJ, Yeo GSH, Moita LF, Bence KK, Jørgensen SB, Coll AP, Breen DM, O'Rahilly S. Activation of the hypothalamic-pituitary-adrenal axis by exogenous and endogenous GDF15. Proc Natl Acad Sci U S A 2021;118:e2106868118. [PMID: 34187898 DOI: 10.1073/pnas.2106868118] [Reference Citation Analysis]
18 Andersson-Hall U, Svedin P, Mallard C, Blennow K, Zetterberg H, Holmäng A. Growth differentiation factor 15 increases in both cerebrospinal fluid and serum during pregnancy. PLoS One 2021;16:e0248980. [PMID: 34043633 DOI: 10.1371/journal.pone.0248980] [Reference Citation Analysis]
19 Moura-Assis A, Friedman JM, Velloso LA. Gut-to-brain signals in feeding control. Am J Physiol Endocrinol Metab 2021;320:E326-32. [PMID: 33284086 DOI: 10.1152/ajpendo.00388.2020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
20 Eddy AC, Trask AJ. Growth differentiation factor-15 and its role in diabetes and cardiovascular disease. Cytokine Growth Factor Rev 2021;57:11-8. [PMID: 33317942 DOI: 10.1016/j.cytogfr.2020.11.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]